Copyright © 2004 by the European Society of Cardiology.
Clinical research
Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty
Department of Cardiology, ISALA Klinieken, Hospital De Weezenlanden, Groot Wezenland, 20, Zwolle 8011 JW, The Netherlands
* Corresponding authors. Tel.: +31-38-4244242; fax: +39-38-4243083
E-mail address: g.deluca{at}diagram-zwolle.nl
Received 12 November 2003; revised 18 March 2004; accepted 24 March 2004 See page 1001 for the editorial comment on this article1
Abstract
Aims The prognostic role of time-to-treatment in primary angioplasty is still a matter of debate. The aim of our study was to evaluate the relationship between time-to-treatment and myocardial perfusion in patients with ST-segment-elevation myocardial infarction (STEMI) treated by primary angioplasty.
Methods and results Our study population consisted of 1072 patients with STEMI treated by primary angioplasty from 1997 to 2001. Myocardial perfusion was evaluated by using ST-segment resolution and myocardial blush grade. Time-to-treatment was defined as the time from symptom-onset to the first balloon inflation. Time-to-treatment was significantly associated with the extent of ST-segment resolution, myocardial blush grade, enzymatic infarct size, and 1-year mortality. After adjustment for baseline confounding factors, time-to-treatment was still associated with impaired ST-segment resolution (adjusted OR [95% CI]=1.01 [1.011.02],
) and myocardial blush (adjusted OR [95% CI]=1.01 [1.011.02],
).
Conclusions This study shows that in patients with STEMI treated by primary angioplasty prolonged ischaemic time is associated with impaired myocardial perfusion, larger infarct size, and higher 1-year mortality. Therefore, all efforts should be made to shorten ischaemic time as much as possible to achieve better myocardial perfusion and myocardial salvage in primary angioplasty for STEMI.
Key Words: Primary angioplasty Myocardial infarction Ischaemic time Myocardial perfusion
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Time is muscle in primary PCI: the strength of the evidence grows
- C.Michael Gibson, James A. de Lemos, Elliott M. Antman, and from the TIMI Study Group
EHJ 2004 25: 1001-1002.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
S. S Rathore, J. P Curtis, J. Chen, Y. Wang, B. K Nallamothu, A. J Epstein, H. M Krumholz, and for the National Cardiovascular Data Registry Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study BMJ, May 19, 2009; 338(may19_1): b1807 - b1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
G De Luca, C M Gibson, F Bellandi, S Murphy, M Maioli, M Noc, U Zeymer, D Dudek, H-R Arntz, S Zorman, et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart, December 1, 2008; 94(12): 1548 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Luca Adjunctive antithrombotic therapy during primary percutaneous coronary intervention Eur. Heart J. Suppl., December 1, 2008; 10(suppl_J): J2 - J14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Buller, Y. Fu, K. W. Mahaffey, T. G. Todaro, P. Adams, C. M. Westerhout, H. D. White, A. W.J. van 't Hof, F. J. Van de Werf, G. S. Wagner, et al. ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial Circulation, September 23, 2008; 118(13): 1335 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tricoci, Y. Lokhnygina, L. G. Berdan, S. R. Steinhubl, D. C. Gulba, H. D. White, N. S. Kleiman, P. E. Aylward, A. Langer, R. M. Califf, et al. Time to Coronary Angiography and Outcomes Among Patients With High-Risk Non ST-Segment Elevation Acute Coronary Syndromes: Results From the SYNERGY Trial Circulation, December 4, 2007; 116(23): 2669 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Boden, K. Eagle, and C. B. Granger Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options J. Am. Coll. Cardiol., September 4, 2007; 50(10): 917 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Napodano, A. Ramondo, and S. Iliceto Adjunctive Thrombectomy in Acute Myocardial Infarction: For Some but Not for All J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1586 - 1586. [Full Text] [PDF] |
||||
![]() |
P. A Ratner, R. Tzianetas, A. W Tu, J. L Johnson, M. Mackay, C. E Buller, M. Rowlands, and B. Reime Myocardial infarction symptom recognition by the lay public: the role of gender and ethnicity. J Epidemiol Community Health, July 1, 2006; 60(7): 606 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
L De Luca, G Sardella, C J Davidson, G De Persio, M Beraldi, T Tommasone, M Mancone, B L Nguyen, L Agati, M Gheorghiade, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction Heart, July 1, 2006; 92(7): 951 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
G De Luca, H Suryapranata, and M Chiariello Aspiration thrombectomy and primary percutaneous coronary intervention Heart, July 1, 2006; 92(7): 867 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 5: Acute Coronary Syndromes Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72. [Full Text] [PDF] |
||||
![]() |
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tarantini, L. Cacciavillani, F. Corbetti, A. Ramondo, M. P. Marra, E. Bacchiega, M. Napodano, C. Bilato, R. Razzolini, and S. Iliceto Duration of Ischemia Is a Major Determinant of Transmurality and Severe Microvascular Obstruction After Primary Angioplasty: A Study Performed With Contrast-Enhanced Magnetic Resonance J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1229 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W.J. van 't Hof, H. van de Wetering, N. Ernst, F. Hollak, F. de Pooter, H. Suryapranata, J. C.A. Hoorntje, J.-H. E. Dambrink, M. Gosselink, F. Zijlstra, et al. A quantitative analysis of the benefits of pre-hospital infarct angioplasty triage on outcome in patients undergoing primary angioplasty for acute myocardial infarction Eur. Heart J. Suppl., October 1, 2005; 7(suppl_K): K36 - K40. [Abstract] [Full Text] [PDF] |
||||
![]() |
H S Gurm and E J Topol The ECG in acute coronary syndromes: new tricks from an old dog Heart, July 1, 2005; 91(7): 851 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. O'Neill, S. R. Dixon, and C. L. Grines The year in interventional cardiology J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1117 - 1134. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J., April 2, 2005; 26(8): 804 - 847. [Full Text] [PDF] |
||||
![]() |
G. De Luca, A. W.J. van 't Hof, J. P. Ottervanger, J. C.A. Hoorntje, A.T. M. Gosselink, J.-H. E. Dambrink, M.-J. de Boer, and H. Suryapranata Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty Eur. Heart J., April 1, 2005; 26(7): 662 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agewall How should we evaluate an open artery in STEMI patients? Eur. Heart J., April 1, 2005; 26(7): 634 - 636. [Full Text] [PDF] |
||||
![]() |
Faster Angioplasty for STEMI Improves Outcomes Journal Watch Emergency Medicine, October 13, 2004; 2004(1013): 1 - 1. [Full Text] |
||||
![]() |
D. Perera, G. Kanaganayagam, and M. Marber Stem cells in unstable angina: the dynamic duo Eur. Heart J., June 2, 2004; 25(12): 999 - 1000. [Full Text] [PDF] |
||||
![]() |
C.M. Gibson, J. A. de Lemos, E. M. Antman, and from the TIMI Study Group Time is muscle in primary PCI: the strength of the evidence grows Eur. Heart J., June 2, 2004; 25(12): 1001 - 1002. [Full Text] [PDF] |
||||







